Development of Extra-Field Products Sample Clauses

Development of Extra-Field Products. (a) The Parties intend that: (i) [ * ] may develop and market a Tularik Extra-Field Product for use within the Pharmaceutical Market; (ii) [ * ] may develop and market a Xxxxx Extra-Field Product for use within the Pharmaceutical Market; (iii) [ * ] may develop and market any Xxxxx Extra-Field Product or Tularik Extra-Field Product for use outside of the Pharmaceutical Market; and (iv) [ * ] may develop and market a Third Party Extra-Field Product for use within or outside the Pharmaceutical Market. A Party that is developing any Extra-Field Product for any such use, or a Tularik Product, as the case may be, shall be the "Developing Party" with respect to such Extra-Field Product and such use or Tularik Product, as the case may be. If [ * ] desires to develop a Tularik Extra-Field Product for use within the Pharmaceutical Market, [ * ] shall disclose in writing to [ * ] the number assigned to the Research Compound upon which such Tularik Extra-Field Product is based prior to [ * ] with respect to such Tularik Extra-Field Product. Xxxxx shall disclose to Tularik the number assigned to the Research Compound upon which: (i) a [ * ] is based, prior to [ * ] with respect to such [ * ]; or (ii) an Extra-Field Product for [ * ]. The Developing Party shall disclose to the non-Developing Party the number assigned to the Research Compound upon which: (i) a Third Party Extra-Field Product is based, prior to [ * ] with respect to such Third Party Extra-Field Product; or (ii) a Third Party Extra-Field Product for [ * ].
Sample 1
AutoNDA by SimpleDocs

Related to Development of Extra-Field Products

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Existing Products Except as set forth below, Contractor shall retain all rights, title and interest in Existing Products.

  • Additional Products Upon satisfying the minimum order requirements above, Enrolled Affiliate may order Additional Products.

  • Licensed Product The term “Licensed Product” shall mean any product (a) the manufacture, use, importation, sale or offer for sale of which would, in the absence of the license granted by this Agreement, infringe a Valid Claim of any of the Licensed Patent Rights, or (b) that is comprised of, utilizes or incorporates Licensed Biological Materials, or (c) that is discovered, developed or made using a Licensed Process.

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.

  • Marking of Licensed Products To the extent commercially feasible and consistent with prevailing business practices, Company shall xxxx, and shall cause its Affiliates and Sublicensees to xxxx, all Licensed Products that are manufactured or sold under this Agreement with the number of each issued patent under the Patent Rights that applies to such Licensed Product.

  • Competing Products The provisions of Section 21 are set forth on attached Exhibit H and are incorporated in this Section 21 by this reference.

  • SOURCE CODE ESCROW FOR LICENSED PRODUCT If Source Code or Source Code escrow is offered by either Contractor or Product manufacturer or developer to any other commercial customers, Contractor shall either: (i) provide Licensee with the Source Code for the Product; or (ii) place the Source Code in a third party escrow arrangement with a designated escrow agent who shall be named and identified to the State, and who shall be directed to release the deposited Source Code in accordance with a standard escrow agreement acceptable to the State; or (iii) will certify to the State that the Product manufacturer/developer has named the State, acting by and through the Authorized User, and the Licensee, as a named beneficiary of an established escrow arrangement with its designated escrow agent who shall be named and identified to the State and Licensee, and who shall be directed to release the deposited Source Code in accordance with the terms of escrow. Source Code, as well as any corrections or enhancements to such source code, shall be updated for each new release of the Product in the same manner as provided above and such updating of escrow shall be certified to the State in writing. Contractor shall identify the escrow agent upon commencement of the Contract term and shall certify annually that the escrow remains in effect in compliance with the terms of this clause. The State may release the Source Code to Licensees under this Contract who have licensed Product or obtained services, who may use such copy of the Source Code to maintain the Product.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!